CNBC October 2, 2023
Annika Kim Constantino

Key Points

– All drugmakers of the first 10 medicines selected for Medicare drug price negotiations have agreed to participate in the price talks.

– President Joe Biden’s Inflation Reduction Act empowered Medicare to negotiate drug prices for the first time in the program’s six-decade history.

– The lengthy negotiation process won’t end until August 2024, with reduced prices going into effect in January 2026.

All drugmakers of the first 10 medicines selected for Medicare drug price negotiations have agreed to participate in the talks, even after many of them sued to halt the process last month.

The companies confirmed their participation in separate statements to CNBC. The Centers for Medicare & Medicaid Services did not immediately respond to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, CMS, Govt Agencies, HHS, Insurance, Medicare, Pharma, Pharma / Biotech
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Bridging the Gap: Pharmacists' Role in Advancing Pharmacogenomic Testing Standards

Share This Article